Craig H. Boyce

Craig Boyce has more than 25 years of strategic consulting and global private equity investing experience, including 18 years with Bain Capital in Boston and Hong Kong. Craig started his career there as a Strategy Consultant, serving on client teams for a variety of industries, and became its Managing Director.

Currently, he is a Managing Partner of the ALS Investment Fund, which supports and finances biotech companies that develop disease modifying therapeutics for ALS, also called Motor Neuron or Lou Gehrig’s disease. The ALS Investment Fund’s first investment, Amylyx (Nasdaq: AMLX), developed the third FDA approved drug for ALS in September 2022.

Over the past two decades, Craig has held several Board positions at for-profit companies, including MYOB, Retail Zoo, and Fleetcor. He’s also volunteered with several nonprofits, including the Nauset/Brewster Regional Little League, The Angel Fund, and the ALS Association-MA Chapter.

Craig received his Bachelor of Science in Chemical Engineering with High Honors from Princeton University, his Master of Science in Chemical Engineering from Massachusetts Institute of Technology, and his master’s degree in business administration, general management from Harvard Business School.

In 2018, he and his wife, Maureen, relocated from Boston to Orleans with their two school-aged children. Since then, he has been active in the community as a Scout leader for Eastham Troops 83 & 183 and a youth soccer, basketball, and baseball coach. We are extremely fortunate to have him on our leadership team.

What has inspired you to serve as a member of The Cape Cod Foundation Board of Directors?
The Cape Cod Foundation’s strong team and impact across our community’s most pressing needs – housing, food security, economic development, mental health, family/youth support and sustainable environment – provide a compelling means to invest resources toward building a better Cape for all.